Microdissection genotyping of gliomas: therapeutic and prognostic considerations

Kleihues, 2000 Schiffer, 1998, Classification and biology of astrocytic gliomas, Forum (Genova)., 8, 244 Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61, 215–225; 226–229. Pollack, 2002, Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification, Curr Oncol Rep, 4, 114, 10.1007/s11912-002-0072-5 Caskey, 2000, Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling, Histol Histopathol, 15, 971 Collins, 1999, Progression as exemplified by human astrocytic tumors, Semin Cancer Biol, 9, 267, 10.1006/scbi.1999.0132 Zagzag, 2000, Molecular events implicated in brain tumor angiogenesis and invasion, Pediatr Neurosurg, 33, 49, 10.1159/000028975 Henson, 2000, Early genetic events in the formation of astrocytomas, Curr Opin Neurol, 13, 613, 10.1097/00019052-200012000-00001 Holland, 2001, Gliomagenesis: genetic alterations and mouse models, Nat Rev Genet, 2, 120, 10.1038/35052535 Maher, 2001, Malignant glioma: genetics and biology of a grave matter, Genes Dev, 15, 1311, 10.1101/gad.891601 Sallinen, 2000, Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques, Cancer Res, 60, 6617 Rickman, 2001, Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis, Cancer Res, 61, 6885 Nishizaki, 1998, Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization, Genes Chromosomes Cancer, 21, 340, 10.1002/(SICI)1098-2264(199804)21:4<340::AID-GCC8>3.0.CO;2-Z Paunu, 2000, Chromosome imbalances in familial gliomas detected by comparative genomic hybridization, Genes Chromosomes Cancer, 29, 339, 10.1002/1098-2264(2000)9999:9999<::AID-GCC1049>3.0.CO;2-8 Rohlff, 2000, Proteomics in molecular medicine: applications in central nervous systems disorders, Electrophoresis, 21, 1227, 10.1002/(SICI)1522-2683(20000401)21:6<1227::AID-ELPS1227>3.0.CO;2-L Rutka, 2000, Molecular biology and neurosurgery in the third millennium, Neurosurgery, 46, 1034, 10.1097/00006123-200005000-00002 Rutka, 2000, Alterations of the p53 and pRB pathways in human astrocytoma, Brain Tumor Pathol, 17, 65, 10.1007/BF02482737 Nagane, 2001, Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications, Cancer Lett, 162, S17, 10.1016/S0304-3835(00)00648-0 Ivanchuk, 2001, The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth, J Neurooncol, 51, 219, 10.1023/A:1010632309113 Finkelstein, 1998, Microdissection-based p53 genotyping: concepts for molecular testing, Mol Diagn, 3, 179, 10.1016/S1084-8592(98)80037-4 Pollack, 2002, Expression of p53 and prognosis in children with malignant gliomas, N Engl J Med, 346, 420, 10.1056/NEJMoa012224 Chozick, 1994, Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis, Cancer, 73, 406, 10.1002/1097-0142(19940115)73:2<406::AID-CNCR2820730228>3.0.CO;2-S Pollack, 1997, The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood, Cancer Res, 57, 304 Pollack, 2001, Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort, Cancer Res, 61, 7404 Finkelstein, 1999, 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice, Am J Pathol, 155, 633, 10.1016/S0002-9440(10)65159-0 Safatle-Ribeiro, 2000, Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus, Cancer Detect Prev, 24, 13 Cong, 2001, Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study, J Cancer Res Clin Oncol, 127, 187, 10.1007/s004320000194 Raja, 2001, Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus, Ann Thorac Surg, 72, 1130, 10.1016/S0003-4975(01)03005-3 Fan, 2001, Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma, Lab Invest, 81, 1429, 10.1038/labinvest.3780356 Rolston, 2001, Distinguishing de novo second cancer formation from tumor recurrence: mutational fingerprinting by microdissection genotyping, J Mol Diagn, 3, 129, 10.1016/S1525-1578(10)60663-0 Rubin, 2001, Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer, J Pathol, 195, 80, 10.1002/path.892 Mariani, 2001, Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection, Cancer Res, 61, 4190 Mariani, 2001, Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro, Clin Cancer Res, 7, 2480 Smit, 2000, Automated extraction and amplification of DNA from whole blood using a robotic workstation and an integrated thermocycler, Biotechnol Appl Biochem, 32, 121, 10.1042/BA20000043 Weiler, 1997, Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays, Nucleic Acids Res, 25, 2792, 10.1093/nar/25.14.2792 Belgrader, 1996, Automated polymerase chain reaction product sample preparation for capillary electrophoresis analysis, J Chromatogr B Biomed Appl, 683, 109, 10.1016/0378-4347(96)00165-X Perry, 1999, Current treatment of oligodendrogliomas, Arch Neurol, 56, 434, 10.1001/archneur.56.4.434 Burton, 1999, New chemotherapy options for the treatment of malignant gliomas, Curr Opin Oncol, 11, 157, 10.1097/00001622-199905000-00003 Perry, 2001, Oligodendrogliomas: clinical and genetic correlations, Curr Opin Neurol, 14, 705, 10.1097/00019052-200112000-00005 Croteau, 2001, New innovations and developments for glioma treatment, Clin Neurosurg, 48, 60 Bigner, 1999, Morphologic and molecular genetic aspects of oligodendroglial neoplasms, Neuro-oncol., 1, 52, 10.1093/neuonc/1.1.52 Biegel, 1999, Cytogenetic and molecular genetics of childhood brain tumors, Neuro-oncol, 1, 139, 10.1215/15228517-1-2-139 Cairncross, 1998, Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas, J Natl Cancer Inst, 90, 1473, 10.1093/jnci/90.19.1473 Paleologos, 1999, Treatment of oligodendroglioma: an update, Neuro-oncol, 1, 61, 10.1215/15228517-1-1-61 Sehgal, 1998, Molecular changes during the genesis of human gliomas, Semin Surg Oncol, 14, 3, 10.1002/(SICI)1098-2388(199801/02)14:1<3::AID-SSU2>3.0.CO;2-F Rasheed, 1999, Molecular pathogenesis of malignant gliomas, Curr Opin Oncol, 11, 162, 10.1097/00001622-199905000-00004 Goussia, 2000, Cytogenetic and molecular abnormalities in astrocytic gliomas (Review), Oncol Rep, 7, 401 Weiss, 2000, Genetics of brain tumors, Curr Opin Pediatr, 12, 543, 10.1097/00008480-200012000-00005 Takeshima, 2000, Application of advances in molecular biology to the treatment of brain tumors, Curr Oncol Rep, 2, 425, 10.1007/s11912-000-0062-4 Hill, 1999, Molecular genetics of brain tumors, Arch Neurol, 56, 439, 10.1001/archneur.56.4.439 Fueyo, 1998, The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies, Neurology, 51, 1250, 10.1212/WNL.51.5.1250 Nozaki, 1999, Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression, Neuro-oncol., 1, 124, 10.1215/S1522851798000179 Bredel, 1999, Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood, Clin Cancer Res, 5, 1786 Sung, 2000, Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas, Brain Pathol, 10, 249, 10.1111/j.1750-3639.2000.tb00258.x Darling, 1998, Biology and genetics of malignant brain tumours, Curr Opin Neurol, 11, 619, 10.1097/00019052-199812000-00002